University of North Carolina at Chapel Hill
Dr. Scott Donaldson is an adult pulmonologist who has focused his career on cystic fibrosis. He is the Associate Director of the UNC Adult CF Center, co-Principal Investigator of the UNC Therapeutic Development Center for CF clinical research, and is Chair of the Translational Advisory Group that represents TDN sites and advises the CFFT. His research focus has been on the measurement of mucociliary clearance (MCC) as an outcome measure for new therapies that target defective MCC in CF.
W37.2- Evaluating serum lipid changes after Ivacaftor initiation in the GOAL study
Saturday, September 28, 2024
10:15 AM – 12:15 PM ET